Subjective cognitive impairment: Towards early identification of Alzheimer disease;Quejas cognitivas subjetivas: hacia una identificación precoz de la enfermedad de Alzheimer

Neurologia

Volumn 31, Issue 8, 2016, Pages 562-571

  Garcia Ptacek, S ^a,b   Eriksdotter, M ^b,c   Jelic, V ^b,c   Porta Etessam, J ^a   Kareholt I ^d,e   Manzano Palomo, S ^f  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e JÖNKÖPING UNIVERSITY   (Sweden)

^f HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Alzheimer disease; Amyloid; Biomarkers; Preclinical stage of Alzheimer disease; Subjective cognitive complaints; Subjective cognitive impairment

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ALZHEIMER DISEASE; AMNESIA; BRAIN ATROPHY; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; INCIDENCE; KNOWLEDGE; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION; PREVALENCE; SHORT SURVEY; SUBJECTIVE COGNITIVE IMPAIRMENT; COGNITION DISORDERS; COGNITIVE DYSFUNCTION; EARLY DIAGNOSIS; PSYCHOLOGY;

ALZHEIMER DISEASE; COGNITION DISORDERS; COGNITIVE DYSFUNCTION; EARLY DIAGNOSIS; HUMANS;

EID: 84876117002     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2013.02.007     Document Type: Short Survey

References (75)

1. 1 Reisberg, B., Ferris, S.H., de Leon, M.J., Crook, T., The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139 (1982), 1136–1139.
2. 2 Reisberg, B., Gauthier, S., Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int Psychogeriatr 20 (2008), 1–16.
3. 3 Jonker, C., Geerlings, M.I., Schmand, B., Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry 15 (2000), 983–991.
4. 4 Andersson C. Predictors of cognitive decline in memory clinic patients. [Doctoral thesis]. Stockholm; 2007.
5. 5 Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the national institute on aging-alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 (2011), 280–292.
6. 6 Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., et al. Global prevalence of dementia: A delphi consensus study. Lancet 366 (2005), 2112–2117.
7. 7 Brookmeyer, R., Johnson, E., Ziegler-Graham, K., Arrighi, H.M., Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3 (2007), 186–191.
8. 8 Cummings, J.L., Alzheimer's disease. N Engl J Med 351 (2004), 56–67.
9. 9 Querfurth, H.W., LaFerla, F.M., Alzheimer's disease. N Engl J Med 362 (2010), 329–344.
10. 10 McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34 (1984), 939–944.
11. 11 Eriksdotter Jonhagen, M., Nordberg, A., Amberla, K., Backman, L., Ebendal, T., Meyerson, B., et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord 9 (1998), 246–257.
12. 12 Dubois, B., Feldman, H.H., Jacova, C., Dekosky, S.T., Barberger-Gateau, P., Cummings, J., et al. Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6 (2007), 734–746.
13. 13 Dubois, B., Feldman, H.H., Jacova, C., Cummings, J.L., Dekosky, S.T., Barberger-Gateau, P., et al. Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9 (2010), 1118–1127.
14. 14 Braak, E., Griffing, K., Arai, K., Bohl, J., Bratzke, H., Braak, H., Neuropathology of Alzheimer's disease: What is new since Alzheimer?. Eur Arch Psychiatry Clin Neurosci 249:Suppl 3 (1999), 14–22.
15. 15 Mistur, R., Mosconi, L., Santi, S.D., Guzman, M., Li, Y., Tsui, W., et al. Current challenges for the early detection of Alzheimer's disease: Brain imaging and csf studies. J Clin Neurol 5 (2009), 153–166.
16. 16 Petersen, R.C., Thomas, R.G., Grundman, M., Bennett, D., Doody, R., Ferris, S., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352 (2005), 2379–2388.
17. 17 Doody, R.S., Ferris, S.H., Salloway, S., Sun, Y., Goldman, R., Watkins, W.E., et al. Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial. Neurology 72 (2009), 1555–1561.
18. 18 Winblad, B., Gauthier, S., Scinto, L., Feldman, H., Wilcock, G.K., Truyen, L., et al. Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology 70 (2008), 2024–2035.
19. 19 Feldman, H.H., Ferris, S., Winblad, B., Sfikas, N., Mancione, L., He, Y., et al. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: The INDDEX study. Lancet Neurol 6 (2007), 501–512.
20. 20 Thal, L.J., Ferris, S.H., Kirby, L., Block, G.A., Lines, C.R., Yuen, E., et al. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 30 (2005), 1204–1215.
21. 21 Barnes, D.E., Yaffe, K., The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10 (2011), 819–828.
22. 22 Lautenschlager, N.T., Cox, K.L., Flicker, L., Foster, J.K., van Bockxmeer, F.M., Xiao, J., et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. JAMA 300 (2008), 1027–1037.
23. 23 Jelic, V., Kivipelto, M., Winblad, B., Clinical trials in mild cognitive impairment: Lessons for the future. J Neurol Neurosurg Psychiatry 77 (2006), 429–438.
24. 24 Mattsson, N., Zetterberg, H., Hansson, O., Andreasen, N., Parnetti, L., Jonsson, M., et al. Csf biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302 (2009), 385–393.
25. 25 Bassett, S.S., Folstein, M.F., Memory complaint, memory performance, and psychiatric diagnosis: A community study. J Geriatr Psychiatry Neurol 6 (1993), 105–111.
26. 26 Blazer, D.G., Hays, J.C., Fillenbaum, G.G., Gold, D.T., Memory complaint as a predictor of cognitive decline: A comparison of african american and white elders. J Aging Health 9 (1997), 171–184.
27. 27 Gagnon, M., Dartigues, J.F., Mazaux, J.M., Dequae, L., Letenneur, L., Giroire, J.M., et al. Self-reported memory complaints and memory performance in elderly french community residents: Results of the PAQUID research program. Neuroepidemiology 13 (1994), 145–154.
28. 28 Geerlings, M.I., Jonker, C., Bouter, L.M., Ader, H.J., Schmand, B., Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am J Psychiatry 156 (1999), 531–537.
29. 29 Jonker, C., Launer, L.J., Hooijer, C., Lindeboom, J., Memory complaints and memory impairment in older individuals. J Am Geriatr Soc 44 (1996), 44–49.
30. 30 Jorm, A.F., Christensen, H., Korten, A.E., Jacomb, P.A., Henderson, A.S., Memory complaints as a precursor of memory impairment in older people: A longitudinal analysis over 7-8 years. Psychol Med 31 (2001), 441–449.
31. 31 Paradise, M.B., Glozier, N.S., Naismith, S.L., Davenport, T.A., Hickie, I.B., Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: A cross-sectional study. BMC Psychiatry, 11, 2011, 108.
32. 32 O'Connor, D.W., Pollitt, P.A., Roth, M., Brook, P.B., Reiss, B.B., Memory complaints and impairment in normal, depressed, and demented elderly persons identified in a community survey. Arch Gen Psychiatry 47 (1990), 224–227.
33. 33 Montejo, P., Montenegro, M., Fernandez, M.A., Maestu, F., Subjective memory complaints in the elderly: Prevalence and influence of temporal orientation, depression and quality of life in a population-based study in the city of madrid. Aging Ment Health 15 (2011), 85–96.
34. 34 Tobiansky, R., Blizard, R., Livingston, G., Mann, A., The Gospel Oak Study stage IV: The clinical relevance of subjective memory impairment in older people. Psychol Med 25 (1995), 779–786.
35. 35 Lamar, M., Dannhauser, T.M., Walker, Z., Rodda, J.E., Cutinha, D.J., Shergill, S.S., Memory complaints with and without memory impairment: The impact of leukoaraiosis on cognition. J Int Neuropsychol Soc 17 (2011), 1104–1112.
36. 36 Fortea, J., Sala-Llonch, R., Bartres-Faz, D., Llado, A., Sole-Padulles, C., Bosch, B., et al. Cognitively preserved subjects with transitional cerebrospinal fluid β-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas. Biol Psychiatry 70 (2011), 183–190.
37. 37 Antonell, A., Fortea, J., Rami, L., Bosch, B., Balasa, M., Sanchez-Valle, R., et al. Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints. J Neural Transm 118 (2011), 259–262.
38. 38 Rodda, J.E., Dannhauser, T.M., Cutinha, D.J., Shergill, S.S., Walker, Z., Subjective cognitive impairment: Increased prefrontal cortex activation compared to controls during an encoding task. Int J Geriatr Psychiatry 24 (2009), 865–874.
39. 39 Rodda, J., Dannhauser, T., Cutinha, D.J., Shergill, S.S., Walker, Z., Subjective cognitive impairment: Functional mri during a divided attention task. Eur Psychiatry 26 (2011), 457–462.
40. 40 Van Oijen, M., de Jong, F.J., Hofman, A., Koudstaal, P.J., Breteler, M.M., Subjective memory complaints, education, and risk of Alzheimer's disease. Alzheimers Dement 3 (2007), 92–97.
41. 41 Amariglio, R.E., Townsend, M.K., Grodstein, F., Sperling, R.A., Rentz, D.M., Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc 59 (2011), 1612–1617.
42. 42 Vazquez Barquero, J.L., Cuestionarios para la evaluación clínica en neuropsiquiatría (SCAN). Adaptación en español. Unidad de investigación en psiquiatría social de Cantabria, 1993, Meditor, Santander.
43. 43 Roth, M., Tym, E., Mountjoy, C.Q., Huppert, F.A., Hendrie, H., Verma, S., et al. Camdex. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149 (1986), 698–709.
44. 44 Abdulrab, K., Heun, R., Subjective memory impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. Eur Psychiatry 23 (2008), 321–330.
45. 45 Riedel-Heller, S.G., Matschinger, H., Schork, A., Angermeyer, M.C., Do memory complaints indicate the presence of cognitive impairment? Results of a field study. Eur Arch Psychiatry Clin Neurosci 249 (1999), 197–204.
46. 46 Dufouil, C., Fuhrer, R., Alperovitch, A., Subjective cognitive complaints and cognitive decline: Consequence or predictor? The epidemiology of vascular aging study. J Am Geriatr Soc 53 (2005), 616–621.
47. 47 Schmand, B., Jonker, C., Geerlings, M.I., Lindeboom, J., Subjective memory complaints in the elderly: Depressive symptoms and future dementia. Br J Psychiatry 171 (1997), 373–376.
48. 48 Jessen, F., Wiese, B., Cvetanovska, G., Fuchs, A., Kaduszkiewicz, H., Kolsch, H., et al. Patterns of subjective memory impairment in the elderly: Association with memory performance. Psychol Med 37 (2007), 1753–1762.
49. 49 Wang, P.N., Wang, S.J., Fuh, J.L., Teng, E.L., Liu, C.Y., Lin, C.H., et al. Subjective memory complaint in relation to cognitive performance and depression: A longitudinal study of a rural chinese population. J Am Geriatr Soc 48 (2000), 295–299.
50. 50 Schmand, B., Jonker, C., Hooijer, C., Lindeboom, J., Subjective memory complaints may announce dementia. Neurology 46 (1996), 121–125.
51. 51 Schofield, P.W., Marder, K., Dooneief, G., Jacobs, D.M., Sano, M., Stern, Y., Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. Am J Psychiatry 154 (1997), 609–615.
52. 52 Chodosh, J., Kado, D.M., Seeman, T.E., Karlamangla, A.S., Depressive symptoms as a predictor of cognitive decline: Macarthur studies of successful aging. Am J Geriatr Psychiatry 15 (2007), 406–415.
53. 53 Enache, D.W., B. Aarsland, D., Depression in dementia: Epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24 (2011), 461–472.
54. 54 Gualtieri, C.T., Johnson, L.G., Age-related cognitive decline in patients with mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008), 962–967.
55. 55 Frodl, T., Meisenzahl, E.M., Zetzsche, T., Born, C., Groll, C., Jager, M., et al. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 159 (2002), 1112–1118.
56. 56 Saczynski, J.S., Beiser, A., Seshadri, S., Auerbach, S., Wolf, P.A., Au, R., Depressive symptoms and risk of dementia: The framingham heart study. Neurology 75 (2010), 35–41.
57. 57 Kramberger, M.G., Jelic, V., Kåreholt, I., Enache, D., Erisdotter Jönhagen, M., Winblad, B., et al. Cerebrospinal fluid alzheimer markers in depressed elderly subjects with and without Alzheimer's disease. Dement Geriatr Cogn Disord 2 (2012), 48–56.
58. 58 Saykin, A.J., Wishart, H.A., Rabin, L.A., Santulli, R.B., Flashman, L.A., West, J.D., et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic mci. Neurology 67 (2006), 834–842.
59. 59 Van der Flier, W.M., van Buchem, M.A., Weverling-Rijnsburger, A.W., Mutsaers, E.R., Bollen, E.L., Admiraal-Behloul, F., et al. Memory complaints in patients with normal cognition are associated with smaller hippocampal volumes. J Neurol 251 (2004), 671–675.
60. 60 Grambaite, R., Stenset, V., Reinvang, I., Walhovd, K.B., Fjell, A.M., Fladby, T., White matter diffusivity predicts memory in patients with subjective and mild cognitive impairment and normal csf total tau levels. J Int Neuropsychol Soc 16 (2010), 58–69.
61. 61 Bookheimer, S.Y., Strojwas, M.H., Cohen, M.S., Saunders, A.M., Pericak-Vance, M.A., Mazziotta, J.C., et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343 (2000), 450–456.
62. 62 Wishart, H.A., Saykin, A.J., Rabin, L.A., Santulli, R.B., Flashman, L.A., Guerin, S.J., et al. Increased brain activation during working memory in cognitively intact adults with the apoe epsilon4 allele. Am J Psychiatry 163 (2006), 1603–1610.
63. 63 Celone, K.A., Calhoun, V.D., Dickerson, B.C., Atri, A., Chua, E.F., Miller, S.L., et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: An independent component analysis. J Neurosci 26 (2006), 10222–10231.
64. 64 Nobili, F., Frisoni, G.B., Portet, F., Verhey, F., Rodriguez, G., Caroli, A., et al. Brain spect in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol 255 (2008), 1344–1353.
65. 65 Barnes, L.L., Schneider, J.A., Boyle, P.A., Bienias, J.L., Bennett, D.A., Memory complaints are related to Alzheimer disease pathology in older persons. Neurology 67 (2006), 1581–1585.
66. 66 Jorm, A.F., Masaki, K.H., Davis, D.G., Hardman, J., Nelson, J., Markesbery, W.R., et al. Memory complaints in nondemented men predict future pathologic diagnosis of Alzheimer disease. Neurology 63 (2004), 1960–1961.
67. 67 Visser, P.J., Verhey, F., Knol, D.L., Scheltens, P., Wahlund, L.O., Freund-Levi, Y., et al. Prevalence and prognostic value of csf markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: A prospective cohort study. Lancet Neurol 8 (2009), 619–627.
68. 68 Rolstad, S., Berg, A.I., Bjerke, M., Blennow, K., Johansson, B., Zetterberg, H., et al. Amyloid-beta42 is associated with cognitive impairment in healthy elderly and subjective cognitive impairment. J Alzheimers Dis 26 (2011), 135–142.
69. 69 Rami, L., Fortea, J., Bosch, B., Sole-Padulles, C., Llado, A., Iranzo, A., et al. Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients. J Alzheimers Dis 23 (2011), 319–326.
70. 70 Perrotin, A., Mormino, E.C., Madison, C.M., Hayenga, A.O., Jagust, W.J., Subjective cognition and amyloid deposition imaging: A Pittsburgh compound B positron emission tomography study in normal elderly individuals. Arch Neurol 69 (2012), 223–229.
71. 71 Chételat, G., Villemagne, V.L., Bourgeat, P., Pike, K.E., Jones, G., Ames, D., et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 67 (2010), 317–324.
72. 72 Chételat, G., Villemagne, V.L., Pike, K.E., Baron, J.C., Bourgeat, P., Jones, G., et al. Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain 133 (2010), 3349–3358.
73. 73 Bouwman, F.H., van der Flier, W.M., Schoonenboom, N.S., van Elk, E.J., Kok, A., Rijmen, F., et al. Longitudinal changes of csf biomarkers in memory clinic patients. Neurology 69 (2007), 1006–1011.
74. 74 Sachdev, P.S., Brodaty, H., Reppermund, S., Kochan, N.A., Trollor, J.N., Draper, B., et al. The Sydney Memory and Ageing Study (MAS): Methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of australians aged 70-90 years. Int Psychogeriatr 22 (2010), 1248–1264.
75. 75 Gallassi, R., Oppi, F., Poda, R., Scortichini, S., Stanzani Maserati, M., Marano, G., et al. Are subjective cognitive complaints a risk factor for dementia?. Neurol Sci 31 (2010), 327–336.